The institute considered 2,608 individual ratings across seven areas, including products and services, innovation, workplace, governance, citizenship, leadership and financial performance. The institute combined the scores into a RepTrak score. Overall, the industry saw a 3.7 percent decrease in reputation scores from 2017.
Here are where nine pharmaceutical companies with a GI presence ranked, along with their RepTrak score:
2. Genentech: 74
3. Celgene: 72.5
4. AbbVie: 72.3
6. Bayer: 70.7
8. Allergan: 69.8
10. McKesson: 68.7
16. AstraZeneca: 64.3
18. Takeda: 61.6
20. Merck: 58.4
To view the whole list, click here.
More articles on gastroenterology:
Ex-Tenet executive claims kickback charges ‘legally flawed’ — 5 insights
Primary care beats surgical organizations in safe injection practices — 4 quick facts
Driving change in outpatient spine surgery: Q&A with Laser Spine Institute CEO Roger Cary
